Reuters logo
BRIEF-Antares Pharma submits NDA to U.S. FDA for quickshot testosterone
December 21, 2016 / 1:13 PM / 9 months ago

BRIEF-Antares Pharma submits NDA to U.S. FDA for quickshot testosterone

Dec 21 (Reuters) - Antares Pharma Inc

* Antares Pharma Inc - submitted a new drug application (nda) to U.S. Food And Drug Administration (FDA) for quickshot testosterone

* Antares Pharma Inc - quickshot testosterone auto injector has not been approved by united states food and drug administration Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below